Effect of dapagliflozin on the initial estimated glomerular filtration rate dip in chronic kidney disease patients without diabetes mellitus.

Ryo ShibataKensei TaguchiYusuke KaidaKei Fukami

Published in: Clinical and experimental nephrology (2022)

DAPA causes an initial dip of eGFR in CKD patients without DM at 1 month after starting DAPA treatment. A higher eGFR at baseline predicts a large initial eGFR dip, which might be linked to the subsequent recovery in eGFR in CKD patients without DM.

Keyphrases

end stage renal disease
chronic kidney disease
small cell lung cancer
ejection fraction
newly diagnosed
epidermal growth factor receptor
tyrosine kinase
prognostic factors
peritoneal dialysis
skeletal muscle
metabolic syndrome
glycemic control